Screener
Xenon Pharmaceuticals XENE Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Xenon Pharmaceuticals’s reported figures.
The source filing: Xenon Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:31 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338244
FAQ
- What is Xenon Pharmaceuticals's free cash flow?
- Xenon Pharmaceuticals (XENE) reported free cash flow of -$95.67M in Q2 2026.
- How has Xenon Pharmaceuticals's free cash flow changed year-over-year?
- Xenon Pharmaceuticals's free cash flow decreased by 48.6% year-over-year, from -$64.39M to -$95.67M.
- What is the long-term trend for Xenon Pharmaceuticals's free cash flow?
- Over 4 years (2021 to 2025), Xenon Pharmaceuticals's free cash flow has grown at a 40.6% compound annual growth rate (CAGR), from -$71.55M to -$279.92M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Xenon Pharmaceuticals's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude